Abstract
Streptococcus agalactiae or group B streptococcus is the cause of various infections in pregnant women and non‐pregnant adults with immunodeficiency, especially diabetics and infants. This bacterium can cause serious infections such as endocarditis, septicemia, meningitis, pneumonia, and urinary tract infections with a high mortality rate. Nowadays, the use of nanoparticles can play a central role in the management of such diseases due to their remarkable biocompatibility and distinct physicochemical characteristics. Nanoparticles are synthesized by various methods such as biological, chemical, and physical, and each has its own unique properties. Nanoparticles have antibacterial, anti‐biofilm, and antiquorum sensing properties in in vitro and in vivo conditions on human pathogens through different pathways. Different nanoparticles displayed that in addition to detecting S. agalactiae, it has antibacterial, antibiofilm, and antiquorum sensing effects on this bacterium. Therefore, the purpose of this review is to investigate different nanoparticles for the detection and effects of antibacterial, anti‐biofilm, and anti‐infestation assays against the human pathogen S. agalactiae.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
